Biogen may get boost from hemophilia drug data

02/10/2013 | American City Business Journals

Recent data from a late-stage study showed promising results for Biogen Idec's two hemophilia drugs, Factor VIII and Factor IX, and FDA approval could mean more jobs at the company. Biogen has filed a regulatory review of Factor IX and is planning to file for Factor VIII in the first half of the year.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
MN
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC